At the time of the study, 18 patients (2.28%) had died, 66.67% were associated with oncological disease, 27.78% with SAID, and 16.67% with IIM, two of whom had anti-TIF1-γ antibodies. This evidence concerns the gene TRIM24 and acquired idiopathic inflammatory myopathy.